About Connecta Therapeutics

Connecta Therapeutics is a biotechnology company that develops new treatments for unresolved medical needs of the central nervous system. It focuses on the development of a first-in-class drug for the treatment of fragile X syndrome.

Company Highlights
Year Founded

2019

icon-altEmployees

8

Location (HQ)

ESP

Since Last Funding

7 months

Monthly Website Visitors

659

icon-altTotal Investment Amt

$4.9M

Last Funding Round

Seed

icon-altMoM Headcount Growth

14.08%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Health Care

Biotechnology

Biotechnology Research

Neuroscience